[
  {
    "question": "A patient in the clinic he has continuous facial jerk and hand jerk (partials continua) how to treat:",
    "option_a": "iv valproic acid",
    "option_b": "iv diazepam",
    "option_c": "iv phenytoin",
    "option_d": "iv \u2026\u2026",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question addresses a type of focal status epilepticus \u2013 continuous partial motor seizures (epilepsia partialis continua) \u2013 where abnormal electrical activity leads to repetitive jerking in specific muscle groups (e.g., face and hand). The immediate goal in management is to terminate the seizure activity, and benzodiazepines are the first\u2010line agents for status epilepticus. In status epilepticus, there is prolonged, unremitting neuronal firing. This occurs because inhibitory GABAergic mechanisms become impaired and excitatory activity becomes dominant. IV benzodiazepines (such as diazepam) enhance GABA-A receptor activity, helping to restore inhibitory tone and rapidly abort seizure activity. With continued seizures, receptor trafficking may render the seizures more refractory, which underpins the urgency of early intervention. A patient with continuous facial and hand jerks is manifesting focal seizure activity. This focal status\u2014despite being limited to specific regions\u2014can evolve and cause structural injury if not controlled promptly. Recognizing the pattern and rapidly instituting therapy is key to preventing worsening neuronal injury. Diagnosis is primarily clinical though EEG confirmation is important if the diagnosis is in doubt. Differential diagnoses include epilepsia partialis continua secondary to structural lesions (e.g., stroke, tumor or infection) and non-epileptic movement disorders. Imaging (CT/MRI) helps evaluate for structural causes, while EEG confirms ongoing epileptiform activity. The latest guidelines (e.g., from the Neurocritical Care Society and ILAE) recommend immediate treatment of status epilepticus. First\u2010line management is IV benzodiazepines (diazepam, lorazepam) due to their rapid onset. If seizures persist, second\u2010line agents such as fosphenytoin, valproic acid, or levetiracetam are considered. In special populations such as pregnant or lactating women, the risks of fetal exposure to benzodiazepines (potential for fetal sedation, withdrawal) are weighed against the emergent need to control seizures, and therapy is individualized. Option A (IV valproic acid) is recognized as a second-line option once benzodiazepines have been tried. Option B (IV diazepam) fits the first-line recommendation for acute seizure termination. Option C (IV phenytoin) is also generally used as a second-line agent. Option D is incomplete. Therefore, Option B is the correct initial treatment. \u2022 In status epilepticus, prompt administration of benzodiazepines is critical, as delays increase morbidity and mortality.  \u2022 Recognize that focal status epilepticus may be due to an underlying lesion; work-up should include neuroimaging. Recent evidence continues to support benzodiazepines as the first-line treatment in all forms of status epilepticus, with multiple guidelines emphasizing rapid administration to improve outcomes. Research is also ongoing concerning the optimal sequencing and combination of second-line agents.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with large left ICA territory infarction with image of CT shown (massive acute infarction), was found to have AFIB what is the appropriate treatment next to start:",
    "option_a": "Aspirin",
    "option_b": "DAPT",
    "option_c": "dabigatran",
    "option_d": "warfarin",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question involves the acute management of a patient with a large left internal carotid territory infarction in the setting of atrial fibrillation (AF). AF is a common cause of cardioembolic stroke. However, in the setting of a massive infarct, the risk of hemorrhagic transformation must be carefully balanced against the benefits of anticoagulation. In patients with AF, emboli originating from the left atrium can lodge in the cerebral circulation (typically the ICA territory), leading to large infarctions. A massive infarct increases the risk of blood\u2013brain barrier disruption and hemorrhagic conversion, which can be exacerbated by early full-dose anticoagulation. The CT showing a massive infarction indicates extensive brain tissue damage. Although AF typically mandates long-term anticoagulation for secondary stroke prevention, immediate initiation post-large infarct could precipitate hemorrhagic transformation. Thus, initial management with an antiplatelet agent is often preferred until the infarct stabilizes. Management begins with neuroimaging (CT/MRI) to assess infarct size and exclude hemorrhage, followed by cardiac evaluation (ECG, echocardiogram) for AF. Differential diagnoses include large artery atherosclerosis and lacunar strokes; however, the presence of AF shifts the etiology toward a cardioembolic source. For massive infarctions in patients with AF, current guidelines (AHA/ASA) recommend delaying full-dose anticoagulation by 1\u20132 weeks to reduce the risk of hemorrhagic transformation. In the acute phase, low-dose aspirin is used for antithrombotic therapy. When transitioning to long-term stroke prevention, direct oral anticoagulants (DOACs; e.g., dabigatran) or warfarin are considered, with DOACs often preferred in non-pregnant adults. For pregnant patients, warfarin is contraindicated, and low-molecular-weight heparin is often chosen, whereas lactating patients may use warfarin safely with monitoring. Option A (Aspirin) is correct as the immediate treatment to bridge the patient while delaying anticoagulation. Option B (Dual antiplatelet therapy) is generally not indicated for cardioembolic strokes. Options C (dabigatran) and D (warfarin) represent long-term anticoagulation strategies but are not initiated immediately in the context of a massive infarct due to the heightened hemorrhagic risk. \u2022 In cardioembolic strokes due to AF, full anticoagulation is essential for secondary prevention but must be timed appropriately after a large infarct.  \u2022 Massive infarcts require cautious initiation of any antithrombotic therapy to prevent hemorrhagic transformation. Current research and recent guideline updates recommend a delayed approach to anticoagulation in large infarcts, highlighting the safety benefit of initial antiplatelet therapy (aspirin) before transitioning to full anticoagulation. Ongoing studies continue to refine the optimum timing balance between reducing recurrence and avoiding hemorrhage.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "SCA artery infarction scenario what you will find also:",
    "option_a": "Rt. ptosis Ipsilateral",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question pertains to identifying additional clinical findings associated with a Superior Cerebellar Artery (SCA) infarction. SCA strokes typically affect structures of the cerebellum, leading to deficits in coordination and balance. The superior cerebellar artery supplies the superior aspect of the cerebellum, including regions responsible for coordinating limb movements and maintaining balance. Infarction in this territory can cause degeneration or dysfunction of the cerebellar cortex and deep nuclei, leading to ipsilateral cerebellar deficits. Patients with SCA infarction may present with ipsilateral limb dysmetria, ataxia, dysdiadochokinesia (impaired ability to perform rapid alternating movements), and sometimes vertigo or nausea. These symptoms help differentiate the infarct from involvement of other cerebellar territories. Diagnosis is made via neuroimaging (MRI is more sensitive than CT for posterior fossa strokes) and clinical examination. Differentiation from infarctions in other cerebellar arterial territories, like the Anterior Inferior Cerebellar Artery (AICA) or Posterior Inferior Cerebellar Artery (PICA), rests on subtle differences in the clinical presentation \u2013 for example, AICA infarcts may also involve facial nerve findings, while PICA infarcts are associated with lateral medullary (Wallenberg) syndrome. Management of an SCA stroke follows guidelines for acute ischemic stroke, including potential thrombolysis if within the therapeutic window, supportive care, and monitoring for complications such as cerebellar edema that could cause brainstem compression. In pregnant women, thrombolysis can be used if indicated after careful risk\u2013benefit analysis, and similar principles apply during lactation with attention to medication safety profiles. Although the option texts are incomplete in this question, Option A mentions \u201cRt. ptosis Ipsilateral\u201d which is more suggestive of an oculomotor or midbrain involvement rather than a cerebellar syndrome. Option B is the marked answer and, based on classical SCA infarct presentations, likely represents clinical signs such as ipsilateral cerebellar ataxia and dysmetria. Without the full list, we assume Option B correctly identifies the typical cerebellar findings seen in SCA infarction. \u2022 SCA infarctions classically produce ipsilateral cerebellar deficits rather than cranial nerve III findings (such as ptosis).  \u2022 A careful clinical examination paired with posterior fossa imaging is crucial in localizing cerebellar strokes. The latest imaging techniques (especially diffusion-weighted MRI) have improved the detection of cerebellar infarcts. Recent stroke guidelines also emphasize a tailored approach to managing posterior circulation strokes, including vigilant monitoring for complications like brainstem compression in cerebellar infarctions.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "30 y/o male found unconscious at street What you expect as the mechanism of injury for attached CT (looked like coup countercoup bleed \"repeated question from previous exam\")",
    "option_a": "Aneurysmal",
    "option_b": "Trauma",
    "option_c": "HTN",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "This question highlights a scenario with a 30\u2010year\u2010old male found unconscious and a CT scan showing a lesion that resembles a coup\u2013countercoup injury. Coup\u2013countercoup injuries are a type of traumatic brain injury (TBI) resulting from blunt force trauma. In coup\u2013countercoup injuries, the brain is injured at the site of impact (coup) and on the opposite side (countercoup) due to the brain's movement within the skull. The rapid deceleration forces generate contusions and bruising, which can lead to intracranial hemorrhage and edema. The patient\u2019s presentation (unconsciousness) combined with CT findings consistent with a coup\u2013countercoup injury points to a trauma-related mechanism. This distinguishes it from aneurysmal bleeds (which usually present with subarachnoid hemorrhage) or hypertensive hemorrhages (which typically affect deep brain structures in older individuals). Diagnosis is established with neuroimaging (CT scan being the first-line modality in acute trauma). Differential diagnoses include aneurysmal subarachnoid hemorrhage and hypertensive intracerebral hemorrhage; however, the imaging pattern and patient profile (young age, history of trauma) point toward a traumatic cause. Management of traumatic brain injury includes stabilization of airway, breathing, and circulation (the ABCs), followed by neuroimaging and neurosurgical evaluation. Intracranial pressure monitoring and supportive care are key components. For pregnant patients, while imaging with CT is generally avoided when possible due to radiation concerns, if necessary, appropriate shielding is used. The same management principles apply with heightened caution. Option A (Aneurysmal) is incorrect as aneurysmal bleeds produce a different pattern (typically subarachnoid hemorrhage) and are less common in a young trauma patient. Option B (Trauma) is the correct answer, accurately reflecting the coup\u2013countercoup injury mechanism. Option C (Hypertension) is unlikely in a 30-year-old with traumatic findings and would more typically produce deep hemorrhages in older patients. \u2022 Coup\u2013countercoup injuries result from inertial forces that damage both the site of impact and the opposite side; always consider trauma in young patients with such CT findings.  \u2022 Rapid identification and management of TBI are critical to prevent secondary brain injury. Recent guidelines on traumatic brain injury emphasize early recognition, stabilization, and neuroimaging. Advances in CT technology have improved the early detection of coup\u2013countercoup lesions, and current management protocols stress the importance of monitoring intracranial pressure and using neuroprotective strategies where appropriate.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A female who develops transverse sinus thrombosis what is the most accurate statement to describe this patient",
    "option_a": "female sex is a major risk",
    "option_b": "seizure is the most common presenting symptoms",
    "option_c": "transverse sinus is the most commonly affected sinus in CVT",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Cerebral venous thrombosis (CVT) is a condition characterized by clot formation in the dural venous sinuses. It disproportionately affects women, largely due to risk factors such as oral contraceptive use, pregnancy, and the postpartum period. In CVT, thrombosis occurs in one or more of the dural venous sinuses resulting in impaired venous drainage, increased intracranial pressure, and possibly venous infarctions or hemorrhages. Hypercoagulable states, frequently encountered in females (e.g., due to estrogen exposure), play a central role. Patients often present with headache (the most common symptom), focal neurological deficits, seizures, and signs of raised intracranial pressure. Although seizures may occur, they are not the predominant presenting feature. The strong female preponderance is a critical clue in the clinical scenario. Diagnosis is made with neuroimaging studies such as magnetic resonance imaging (MRI) combined with magnetic resonance venography (MRV). Differentials include migraines, meningitis, intracerebral hemorrhage, and subarachnoid hemorrhage, but the clinical context along with imaging aids in differentiation. First-line management involves anticoagulation with low molecular weight heparin (LMWH) even in cases with hemorrhagic transformation. In pregnancy and lactation, LMWH is preferred due to its safety profile. Subsequent management includes transitioning to oral anticoagulants with appropriate monitoring and risk factor modification. Option A (female sex is a major risk) is correct, as women are indeed at higher risk due to hormonal factors and related hypercoagulable states. Option B is incorrect because, although seizures can occur, headache remains the most common presenting symptom. Option C, while noting that the transverse sinus is a common site, is less accurate as literature variably points to both the superior sagittal and transverse sinuses; moreover, the emphasis on female risk makes option A more specific in this context. 1. Always assess for prothrombotic risk factors in women with CVT. 2. Headache is the most common presenting symptom in CVT. 3. Early anticoagulation is key to reducing morbidity. Recent guidelines and research from the American Heart Association (AHA) endorse prompt anticoagulation in CVT. Studies continue to clarify which sinus is most commonly involved, yet the strong female predisposition remains universally acknowledged.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Site of lesion in weber syndrome",
    "option_a": "Base of midbrain",
    "option_b": "tegmentum",
    "option_c": "tectum",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Weber syndrome is a classical brainstem stroke syndrome characterized by ipsilateral oculomotor nerve dysfunction (manifesting as ptosis and ophthalmoplegia) and contralateral motor deficits. It results from a lesion in the midbrain. The syndrome is typically due to infarction or hemorrhage at the ventral (basal) portion of the midbrain affecting the exiting fibers of the oculomotor nerve and the corticospinal tracts that travel through the cerebral peduncles. The lesion is usually vascular in origin, commonly involving branches of the posterior cerebral artery. Patients present with an ipsilateral third cranial nerve palsy (leading to diplopia and ptosis) along with contralateral hemiparesis, which reflects the involvement of adjacent motor pathways. Neuroimaging (MRI with diffusion-weighted imaging) is key in confirming the lesion in the ventral midbrain. Differential diagnoses include other midbrain syndromes such as Benedikt\u2019s syndrome, which additionally includes tremor and ataxia due to red nucleus involvement. Acute management follows standard stroke protocols including thrombolysis (if within window and no contraindications), blood pressure control, and supportive care. For patients who are pregnant or lactating, thrombolytic therapy and supportive measures are considered on a case-by-case basis following current AHA/ASA guidelines, with multidisciplinary consultation. Option A (Base of midbrain) is correct because Weber syndrome classically involves the ventral midbrain (basis pedunculi), not the tegmentum (dorsal aspect) or the tectum (posterior aspect). 1. Weber syndrome is marked by the combination of oculomotor dysfunction and contralateral motor weakness. 2. Lesions are localized to the ventral midbrain. 3. Vascular supply from the posterior cerebral artery is typically implicated. Recent imaging studies and guidelines continue to support the ventral midbrain localization in Weber syndrome. Management strategies align with broader ischemic stroke management protocols adapted to brainstem strokes.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A man who has right side weakness and dysphasia, on stroke work up he was found to have left MCA severe stenosis what is the most appropriate management:",
    "option_a": "endarterectomy",
    "option_b": "stenting",
    "option_c": "Aspirin and plavix",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "A patient with right-sided weakness and dysphasia with left MCA stenosis is suffering an ischemic stroke related to intracranial atherosclerotic disease. The appropriate management of such a condition involves medical therapy rather than invasive procedures. Atherosclerotic disease of the left middle cerebral artery leads to luminal narrowing, reduced cerebral perfusion, and ultimately ischemia in the dependent brain territories. The resulting stroke produces contralateral motor and language deficits due to involvement of the dominant hemisphere. The presentation of right-sided weakness and dysphasia reflects the involvement of the left MCA territory, which is responsible for motor control of the contralateral side of the body and language functions (in the dominant hemisphere). Diagnosis involves neuroimaging with CT/MRI to confirm infarct and vessel imaging (CTA/MRA) to assess the degree of stenosis. Differential considerations include embolic stroke from cardiac sources and lacunar strokes. Carotid duplex is more relevant for extracranial disease. First-line management is aggressive medical therapy with dual antiplatelet therapy (typically aspirin and clopidogrel) for a duration based on recent trials (e.g., 21-90 days, often 90 days in high-risk individuals). Second-line interventions, such as stenting or endarterectomy, are largely reserved for extracranial stenosis (e.g., carotid endarterectomy) and are not first-line for intracranial lesions. In pregnant or lactating patients with stroke, low-dose aspirin is generally considered safe, with careful multidisciplinary management tailoring the risk\u2013benefit ratio. Option A (endarterectomy) is typically used for extracranial carotid stenosis and is not indicated for intracranial MCA stenosis. Option B (stenting) has been explored in clinical trials (e.g., SAMMPRIS) but has shown higher periprocedural risks compared to aggressive medical management. Option C (Aspirin and Plavix) is correct, representing the current standard of care for symptomatic intracranial atherosclerotic disease. 1. Intracranial atherosclerotic strokes are best managed medically with dual antiplatelet therapy. 2. Differentiation between intracranial and extracranial pathology is crucial when considering revascularization strategies. 3. SAMMPRIS trial data influenced the move toward medical management in these cases. Recent trials, notably the SAMMPRIS study, have reinforced that aggressive medical management (including dual antiplatelet therapy and risk factor modification) provides superior outcomes compared to stenting for intracranial stenosis.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A patient who presented with inability to read his own hand writing, his comprehension for spoken language, fluency and repetition is normal (nothing was mentioned on his ability to write) what is the most common artery :",
    "option_a": "PCA",
    "option_b": "PICA",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "The clinical presentation described is that of pure alexia (alexia without agraphia), a syndrome in which patients lose the ability to read despite preserved writing abilities and intact spoken language comprehension. This syndrome is most commonly encountered with infarcts in the territory of the left posterior cerebral artery (PCA), particularly affecting the left occipital lobe and often involving the splenium of the corpus callosum. The lesion disrupts visual processing and the transfer of visual information to language areas. Patients with this syndrome can write and speak fluently, but when they attempt to read, whether it is their own writing or printed words, they are unable to decode the visual stimuli into meaningful language. This dissociation between reading and writing highlights the localization of the lesion. Neuroimaging (MRI) is essential for localizing the infarct, which typically involves the left occipital lobe. Differential diagnoses include other language disorders such as aphasia; however, in pure alexia, the preservation of spoken language distinguishes it from more global aphasic syndromes. Acute management follows standard ischemic stroke protocols, including consideration for thrombolytic therapy if within the appropriate time window. Long-term management involves antiplatelet therapy, risk factor modification, and rehabilitation (including occupational and speech therapy). In pregnant or lactating patients, aspirin is typically acceptable with multidisciplinary review to balance risks and benefits, while thrombolytic therapy is used only under strict guidelines. Option A (PCA) is correct because the syndrome of pure alexia is most commonly associated with infarcts in the left PCA territory. Option B (PICA) is incorrect as it typically supplies parts of the cerebellum and lateral brainstem rather than the occipital lobe. 1. Pure alexia (alexia without agraphia) is a disconnection syndrome resulting from left occipital infarct and splenial involvement. 2. The preservation of writing despite impaired reading is a key diagnostic feature. 3. The left PCA is the most often implicated vessel in this syndrome. Recent research emphasizes the role of detailed neuroimaging in localizing lesions in stroke syndromes. Current stroke management guidelines continue to support prompt intervention in PCA strokes, with tailored approaches for special populations including pregnant and lactating patients.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Image of DWI showing watershed infarction in one side what to do :",
    "option_a": "CTA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Watershed infarctions occur at the border zones between major cerebral arteries. In cases where DWI imaging shows a unilateral watershed pattern, it raises concern for hemodynamic compromise, most commonly due to an upstream arterial stenosis (often in the internal carotid artery). The next logical step is to evaluate the vascular anatomy, which is best done with vascular imaging such as a CTA. Watershed zones are vulnerable to hypoperfusion. When there is significant stenosis or occlusion (commonly in the carotid circulation), these areas receive less than adequate blood flow, resulting in infarcts. CTA helps identify the site and severity of arterial narrowing, guiding further management. Patients with watershed strokes can present with variable neurological deficits depending on the exact regions affected. The imaging pattern on DWI is distinct, and identifying the cause (such as carotid stenosis) is essential as it may alter future management, including possible revascularization procedures. Once DWI suggests a watershed infarct, vascular imaging (CTA in this case) is indicated. Differential diagnoses include embolic strokes and small vessel disease strokes; however, their imaging and clinical histories usually differ. CTA helps differentiate a hemodynamic mechanism from an embolic one by showing vascular narrowing or occlusion. After identifying a watershed infarct with CTA, management includes optimizing blood pressure, antiplatelet therapy, and addressing the underlying cause such as carotid atherosclerosis. For patients who are pregnant or lactating, CTA can be performed with proper shielding, and risk factor management (blood pressure, lipids) should follow guidelines that take maternal and fetal safety into account. Option A (CTA) is correct because it provides crucial information on the vascular status (e.g., carotid/vertebral arteries) that likely contributed to the watershed infarct. The other options were either not provided or not appropriate for the next step in this scenario. 1) Unilateral watershed infarctions on DWI should prompt an evaluation for significant ipsilateral carotid stenosis. 2) Vascular imaging is a key next step in differentiating hemodynamic strokes from embolic phenomena. Recent AHA/ASA guidelines emphasize early vessel imaging in acute ischemic stroke patients. Emerging research also supports the prompt use of CTA to lay the groundwork for possible interventions such as carotid revascularization if significant stenosis is identified.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Clear scenario of old man presented within the window of tpa about what to give:",
    "option_a": "Tpa",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Intravenous thrombolytic therapy (tPA) is the standard treatment for acute ischemic stroke if the patient is within the appropriate therapeutic window and meets eligibility criteria. The scenario describes an elderly man who is within this window. tPA works by catalyzing the conversion of plasminogen to plasmin, the enzyme responsible for breaking down fibrin clots. In the context of an ischemic stroke, the timely dissolution of the clot can restore blood flow, salvaging penumbral brain tissue. Patients presenting with acute stroke symptoms require rapid evaluation including a non-contrast CT to exclude hemorrhage. If within 3-4.5 hours (and meeting other criteria) tPA is recommended. The older man in the scenario is an appropriate candidate assuming no contraindications are found on further workup. Initial assessment requires neuroimaging (usually a CT scan) to rule out hemorrhage. After confirming an ischemic event, the patient\u2019s history, time of symptom onset, and contraindications are reviewed. Differential diagnoses include stroke mimics like seizures or migraine, but the acute focal neurological deficits help distinguish true stroke. The first-line management for eligible patients with acute ischemic stroke is IV tPA, ideally given within 3 to 4.5 hours of symptom onset. Subsequent treatments may include endovascular therapies if a large vessel occlusion is found. In pregnant or lactating women, tPA has been used with caution in select cases after weighing maternal and fetal risks, and consultation with specialists is advised. Option A (tPA) is correct because the patient fits the criteria for thrombolysis. The other possible options (though not provided) would likely include alternatives not appropriate in the acute phase or less evidence-based interventions. 1) Time is brain \u2013 rapid recognition and treatment of acute ischemic stroke significantly improves outcomes. 2) Exclusion of hemorrhage via CT is essential before administering tPA. The latest guidelines continue to support IV tPA in eligible acute ischemic stroke patients. Recent studies have also explored extended time windows and advanced imaging techniques, but standard practice remains to initiate tPA as early as possible within the defined window.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with weakness hemianesthesia and tongue deviation (? medial medullary syndrome):",
    "option_a": "Vertebral artery",
    "option_b": "Anterior spinal artery (was not in options)",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Medial medullary syndrome, also known as Dejerine syndrome, is a brainstem stroke syndrome characterized by a triad of contralateral motor deficits, contralateral loss of proprioception/tactile sensation, and ipsilateral tongue deviation. The syndrome is most classically attributed to infarction in the territory supplied by the anterior spinal artery. The medial medulla is supplied primarily by the anterior spinal artery, a branch arising from the vertebral arteries. Occlusion of this vessel leads to infarction of structures in the medial medulla including the pyramids (causing weakness), medial lemniscus (affecting sensation), and the hypoglossal nerve nucleus (resulting in tongue deviation). Clinically, patients typically present with contralateral hemiparesis and hemisensory loss along with tongue deviation toward the side of the lesion. This constellation of signs helps differentiate medial medullary syndrome from other brainstem strokes such as lateral medullary (Wallenberg) syndrome. Brain MRI with diffusion-weighted imaging is the modality of choice to identify medullary infarcts. To differentiate medial medullary syndrome from other brainstem strokes, vascular imaging (CTA or MRA) can be employed to assess the vertebral and anterior spinal arteries. Differential diagnoses include lateral medullary syndrome and pontine strokes, which have different clinical and imaging features. The management of medial medullary syndrome involves standard acute ischemic stroke protocols including potential thrombolysis, antiplatelet therapy thereafter, and aggressive risk factor management (e.g., controlling hypertension, dyslipidemia). In pregnant or lactating patients, treatment must be balanced with safety concerns, and nonpharmacologic measures or medications with established safety profiles in pregnancy should be considered. Option B (Anterior spinal artery) is considered correct because infarction in medial medullary syndrome is most commonly due to occlusion of the anterior spinal artery. Option A (Vertebral artery) is less specific \u2013 although the vertebral artery gives rise to the anterior spinal artery, the classic lesion localizes to the territory of the anterior spinal artery rather than from a direct vertebral artery occlusion. 1) Medial medullary syndrome typically presents with contralateral hemiparesis and hemisensory loss with ipsilateral tongue weakness. 2) The anterior spinal artery, often a branch of the vertebral artery, is the vessel most commonly implicated in this syndrome. Recent MRI-based studies and advanced vascular imaging have reinforced the role of the anterior spinal artery in medial medullary syndrome. Guidelines continue to advocate for rapid imaging and tailored management strategies in brainstem strokes.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Long scenario for patient with obesity and HTN and high BMI asking about best way for stroke prevention, vital signs and labs provided showed high b/p and hba1c around 6.9. And he is taking ant HTN and statin but not any dm medication:",
    "option_a": "Perindopril",
    "option_b": "Metformin",
    "option_c": "Or weight reduction",
    "option_d": "Aspirin",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Stroke prevention in patients with multiple risk factors (such as obesity and hypertension) is most effectively achieved through a multifactorial approach that focuses on modifiable lifestyle factors. In a patient already on antihypertensive and statin medication with borderline glycemic control (HbA1c ~6.9), weight reduction can significantly reduce overall stroke risk. Obesity contributes to a pro-inflammatory state, insulin resistance, dyslipidemia, and increased blood pressure\u2014all of which favor atherosclerosis and increase the risk of stroke. Weight reduction has been shown to improve these metabolic parameters and reduce vascular inflammation. Patients with obesity and hypertension are at an elevated risk for stroke due not only to high blood pressure but also because obesity worsens other metabolic risk factors. Weight reduction, therefore, becomes a central pillar of primary stroke prevention in such individuals. A thorough clinical assessment including vital signs, laboratory studies (such as HbA1c, fasting glucose, and lipid profile), and measurement of BMI is key for risk stratification. Differential diagnoses for stroke prevention strategies could include adjustments in antihypertensive regimes or initiation of diabetes medications, but lifestyle modification remains universally recommended as first-line. The first-line management for such a patient is lifestyle modification\u2014with weight reduction being paramount. This includes dietary changes, increased physical activity, and sometimes structured weight loss programs. While continuing antihypertensives and statins is essential, adding medications like metformin is reserved for established type 2 diabetes mellitus. Aspirin is not routinely recommended for primary prevention in all patients due to bleeding risks. In pregnancy and lactation, lifestyle modifications are especially prioritized to avoid medication side effects. Option C (Weight reduction) is the best answer since it addresses the root modifiable risk factor. Option A (Perindopril) is already part of his antihypertensive regimen and further intensification would depend on blood pressure targets. Option B (Metformin) is not indicated unless he meets criteria for diabetes. Option D (Aspirin) has a limited role in primary prevention due to potential bleeding risks and is not the most effective choice here. 1) Lifestyle modification, especially weight reduction, is the cornerstone of primary stroke prevention in obese patients. 2) Optimizing modifiable risk factors (hypertension, hyperglycemia, dyslipidemia) can significantly reduce stroke risk. Current guidelines emphasize the importance of a multifactorial approach to stroke prevention, with weight reduction being a key intervention. Recent studies have also highlighted the benefits of lifestyle modifications on cardiovascular outcomes, and these recommendations remain applicable in special populations (e.g., pregnant or lactating individuals) to minimize medication exposure when possible.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "A woman presented with acute left sided weakness and dysarthria a right ICH was found on CT (image shown without mentioning the diagnosis) patient vital signs as follows BP 167 systolic, what is the most appropriate management:",
    "option_a": "labetalol",
    "option_b": "factor 7 infusion",
    "option_c": "referral for NS for (minimally invasive?) evacuation",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Acute intracerebral hemorrhage (ICH) requires immediate management to prevent further bleeding and secondary brain injury. The core principle is to stabilize the patient by controlling blood pressure, which can reduce hematoma expansion and improve outcomes. In ICH, a ruptured cerebral vessel causes blood to accumulate within the brain parenchyma. Elevated blood pressure increases hydrostatic pressure on the vulnerable vessel walls, risking continued bleeding and hematoma enlargement. Controlling blood pressure minimizes further vessel disruption and secondary damage. A patient presenting with acute left-sided weakness and dysarthria, in the context of a right-sided hemorrhage on CT, reflects the neurological deficits caused by mass effect and neuronal injury. The moderately elevated systolic pressure (167 mm Hg) is significant enough in this setting to justify immediate antihypertensive therapy. The gold standard in the acute setting is a non-contrast CT scan to identify ICH. Differential diagnoses include ischemic stroke (which typically shows no blood on the CT scan), subarachnoid hemorrhage (which has a different distribution on imaging), and stroke mimics such as tumors or seizures. Rapid imaging confirms the diagnosis, guiding early management. First-line management involves aggressive yet controlled blood pressure reduction using IV agents. Labetalol is a common first-line agent because of its rapid action and easy titration. Second-line approaches include using agents like nicardipine if labetalol is contraindicated. Neurosurgical intervention is reserved for cases with mass effect, imminent herniation, or specific locations (e.g., cerebellar hemorrhage). In pregnant and lactating patients, labetalol is also the antihypertensive of choice due to its well\u2010established safety profile in these populations. Option A (labetalol) is correct because it is effective in controlling blood pressure in the acute ICH setting. Option B (factor 7 infusion) is not indicated; recombinant activated factor VII has been studied in hemorrhage but is associated with thrombotic risks and is not standard care in ICH. Option C (referral for neurosurgery for evacuation) is typically reserved for selected cases (e.g., cerebellar hemorrhages or those with significant mass effect) and is not the immediate priority in a patient with modest blood pressure elevation and a spontaneous ICH. \u2022 Rapid blood pressure control is a cornerstone in preventing hematoma expansion in ICH.\n\u2022 Labetalol is safe and effective, including in pregnant and lactating patients.\n\u2022 Neurosurgical intervention is indicated only in select cases, not as the primary immediate treatment. Recent trials such as INTERACT2 and ATACH-II support early and aggressive blood pressure lowering in ICH. The AHA/ASA guidelines recommend similar approaches, and labetalol remains a preferred agent due to its safety profile and efficacy.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about TIA management:",
    "option_a": "Dual antiplatelet",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Transient ischemic attack (TIA) represents a temporary period of cerebral ischemia without permanent infarction. The primary goal is stroke prevention, and dual antiplatelet therapy (DAPT) has been shown to reduce early recurrent stroke risk in high-risk or minor TIA patients. TIAs typically result from transient thromboembolic events that temporarily interrupt cerebral blood flow. Platelet aggregation plays a crucial role in clot propagation, and using two antiplatelet agents can interrupt this process, reducing the risk of full-blown stroke. Patients with TIA often have transient symptoms that resolve completely yet signal an increased risk for future stroke. Prompt initiation of therapy is thus essential to reduce this high early risk. Diagnosis involves a careful clinical history and supportive imaging (brain CT or MRI) to rule out acute infarction. Differential diagnoses include migraine with aura, seizures, and other non-vascular events. Risk stratification scores, such as the ABCD2 score, help assess the risk of stroke following a TIA. First-line treatment for high-risk TIA typically involves dual antiplatelet therapy (e.g., aspirin plus clopidogrel) for a short course (typically 21\u201390 days) based on evidence from the CHANCE and POINT trials. Subsequent management includes long-term single antiplatelet therapy, risk factor modification (such as blood pressure and cholesterol control), and lifestyle changes. In pregnancy, low-dose aspirin is generally considered safe, but clopidogrel has less robust data; decisions should weigh risks versus benefits carefully. In lactating patients, aspirin at low doses is acceptable, though caution with clopidogrel is advised. Option A (Dual antiplatelet therapy) is correct as studies have demonstrated its efficacy in reducing early recurrent stroke risk in TIA patients. Although other options exist (such as single antiplatelet therapy, anticoagulation, or immediate statin therapy), the evidence clearly supports short-term DAPT in patients with high-risk TIA. \u2022 TIA is a critical warning sign for stroke; prompt DAPT can significantly reduce recurrence risk.\n\u2022 The CHANCE and POINT trials established the role of DAPT in the early management of TIA.\n\u2022 Risk factor modification remains an essential part of long-term stroke prevention. Recent guidelines, supported by the CHANCE and POINT trials, advise the use of dual antiplatelet therapy for a limited period immediately following a high-risk TIA to reduce early recurrent stroke risk.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about a patient with A.COM aneurysm, which of the following factor is the most predictive of aneurysm rupture:",
    "option_a": "Size",
    "option_b": "Acom location less likely to rupture",
    "option_c": "Uncontrolled b/p",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Risk stratification in patients with intracranial aneurysms involves identifying features that most strongly predict rupture. Aneurysm size remains a critical factor in many validated scoring systems and risk models. The rupture of an aneurysm is primarily due to hemodynamic stress and wall weakening. Larger aneurysms have increased wall tension, making them more susceptible to rupture. Other factors, such as location and uncontrolled hypertension, also contribute, but size is often the primary measurable predictor. Aneurysms located at the anterior communicating (ACOM) artery carry an inherently higher risk of rupture even when they are small. However, the overall risk of rupture increases in correlation with aneurysm size, which is used to guide the decision towards surgical or endovascular repair. Imaging tests, including CT angiography (CTA), MR angiography (MRA), or digital subtraction angiography (DSA), are used to evaluate aneurysm size, shape, and location. Differential diagnoses include pseudoaneurysms or vascular malformations. Detailed imaging is necessary to discern the rupture risk and plan management. Management is tiered: small, low-risk aneurysms may be observed with serial imaging, while larger aneurysms (or those with concerning features) are managed with surgical clipping or endovascular coiling. Aggressive blood pressure control is important in all patients. In pregnant or lactating patients, treatment plans are individualized; non-ionizing imaging modalities and careful management of blood pressure and anesthesia risks are prioritized. Option A (Size) is correct because numerous studies and risk scoring systems (like PHASES) underscore aneurysm size as the most predictive factor of rupture. Option B is incorrect because aneurysms in the anterior communicating artery are known to have a higher rupture risk rather than being 'less likely' to rupture. Option C (Uncontrolled blood pressure), while a modifiable risk factor for rupture, is less predictive than the inherent structural feature of aneurysm size. \u2022 Aneurysm size is a key criterion in determining rupture risk; aneurysms above certain thresholds (e.g., >7 mm) are higher risk.\n\u2022 ACOM aneurysms are particularly dangerous and may rupture even at smaller sizes.\n\u2022 Integrating size with other factors (such as morphology and location) improves risk stratification. Recent systematic reviews and updated scoring systems continue to emphasize the predictive value of aneurysm size. The PHASES score remains a widely used tool in clinical practice, alongside emerging research that refines risk prediction models.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with sickle cell anemia wants to check on himself because his brother is also sickler and had previous stroke. How to predict:",
    "option_a": "Transcranial doppler",
    "option_b": "CTA",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "In patients with sickle cell disease (SCD), the risk of cerebrovascular complications including stroke is significantly heightened. Transcranial Doppler (TCD) ultrasound is the validated screening tool designed to measure cerebral blood flow velocities, which are correlated with stroke risk. Sickle cell anemia leads to chronic endothelial injury and vasculopathy, resulting in arterial stenosis. As vessels narrow, blood flow velocity increases, which can be detected by TCD. Elevated velocities indicate a compensatory mechanism for reduced lumen diameter and predict an increased risk of ischemic stroke. Screening with TCD is particularly important in children with SCD, as early identification of abnormal flow velocities allows for timely intervention (e.g., chronic transfusion therapy) to reduce stroke risk. Even in adult patients, TCD may help in risk assessment if there is a concerning family or personal history of stroke. TCD is non-invasive, cost-effective, and has no radiation exposure, making it ideal for repeated screening. Alternative imaging (such as CTA or MRA) may further delineate vascular anatomy but are not used for routine screening due to risks associated with radiation and contrast use. If TCD screening reveals elevated cerebral blood flow velocities, the first-line management is typically the initiation of a chronic red cell transfusion program to reduce the risk of stroke. Hydroxyurea is another option that may be used to reduce sickling. In pregnant or lactating patients, careful management is needed to balance the benefits of transfusion therapy with potential complications, and non-ionizing imaging like TCD remains the preferred screening modality. Option A (Transcranial Doppler) is correct because it is the standard, widely recommended screening tool for predicting stroke risk in individuals with sickle cell disease. Option B (CTA) is less favored due to the exposure to radiation and contrast agents, and it is not validated as a screening tool in this population. \u2022 TCD screening in children with sickle cell disease has significantly reduced the incidence of first strokes.\n\u2022 Elevated cerebral blood flow velocities on TCD are a strong predictor of stroke risk.\n\u2022 TCD is safe for repeated use and is especially valuable in the pediatric population. Seminal trials such as STOP and STOP II have validated the use of TCD screening to identify high-risk patients and guide preventative interventions. Current guidelines continue to recommend TCD as the cornerstone screening tool for stroke prevention in sickle cell disease.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario of stroke with normal CT what do next (not thrombolysis):",
    "option_a": "CTA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "In the acute stroke setting, a non-contrast CT scan is typically the first imaging modality used to exclude hemorrhage. However, early in ischemic stroke, CT may appear normal due to the time lag before radiographic changes become evident. Thus, vascular imaging such as CT angiography (CTA) is critical to evaluate the cerebral vessels for occlusions or stenoses, especially when thrombolysis isn\u2019t an option. Ischemic strokes result from an interruption of blood flow, often due to an occlusive thrombus or embolus. In the hyperacute phase, cytotoxic edema has not yet produced clear changes on CT. CTA, by visualizing the cerebral vasculature, can detect large vessel occlusions which underlie the infarct and help determine patient eligibility for interventions such as thrombectomy. Patients presenting with clinical signs of stroke may have a normal CT scan if imaged very early. CTA is then utilized to assess for large vessel occlusions that may not be evident on non-contrast CT, guiding further management decisions. Recognizing that a normal CT can be misleading is key to timely diagnosis and treatment. The differential diagnosis includes transient ischemic attack (TIA), migraine with aura, and other conditions mimicking stroke. The diagnostic approach generally begins with a non-contrast CT to exclude hemorrhage, followed by CTA or CT perfusion studies to evaluate ischemic tissue and vascular status. Current guidelines recommend rapid imaging in suspected stroke. When CT is normal in a patient with stroke symptoms, a CTA is indicated to identify occlusions that could be amenable to endovascular therapy. In patients who are pregnant or lactating, the benefits of CTA (with appropriate shielding) outweigh the risks, as early detection and intervention are critical. Option A (CTA) is correct because it offers detailed visualization of the cerebral arteries. The other options are not provided, but among available choices, CTA is the most appropriate next investigation when the initial non-contrast CT is normal. 1. A normal CT in the hyperacute phase does not exclude ischemic stroke. 2. CTA is essential for diagnosing large vessel occlusion. 3. Rapid vascular imaging guides potential subsequent interventions. Recent AHA/ASA guidelines emphasize the role of CTA in the early evaluation of ischemic stroke, particularly when CT findings are inconclusive and large vessel occlusion is suspected. Studies support that CTA enables rapid decision-making for possible endovascular therapy.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about Wernicke aphasia which artery:",
    "option_a": "Inferior division of MCA",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Wernicke\u2019s aphasia is characterized by impaired language comprehension paired with fluent but often nonsensical speech. It results from damage to the language processing center, typically located in the posterior portion of the superior temporal gyrus. Wernicke\u2019s area is predominantly supplied by the inferior division of the middle cerebral artery (MCA) in the dominant hemisphere\u2014most often the left. Occlusion or infarction in this region disrupts language comprehension while sparing speech fluency, producing the classical picture of Wernicke\u2019s aphasia. Clinically, patients with Wernicke\u2019s aphasia present with fluent speech that may include paraphasias and neologisms, along with significant comprehension deficits. Recognizing the vascular territory affected helps correlate the clinical syndrome with its underlying vascular pathology. The differential diagnosis includes other aphasic syndromes such as Broca\u2019s aphasia, conduction aphasia, and transcortical sensory aphasia. Neuroimaging (typically MRI with appropriate sequences) confirms the infarct location and its vascular distribution. Management of stroke affecting Wernicke\u2019s area follows standard ischemic stroke protocols, including considerations for thrombolysis or thrombectomy if within the treatment window. For pregnant or lactating patients, similar stroke protocols apply with adjustments to imaging and medication selection. Subsequent rehabilitation with speech and language therapy is crucial. Option A (Inferior division of MCA) is correct because this artery supplies Wernicke\u2019s area. Other options, though not listed here, do not accurately correspond to the vascular supply of the language comprehension center. 1. Wernicke's aphasia presents with fluent but nonsensical speech and impaired comprehension. 2. It is most commonly due to infarction in the territory of the inferior division of the left MCA. 3. Detailed neuroimaging is essential to confirm the lesion\u2019s location. Current neuroimaging studies and stroke guidelines consistently affirm that the inferior division of the MCA supplies Wernicke's area. Emerging research continues to refine our understanding of aphasia subtypes and optimal rehabilitation strategies.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Patient with Sickle Cell Anemia who with symptoms of infarction, in investigation he was found to have severe intracranial MCA stenosis what would you do",
    "option_a": "ASA",
    "option_b": "Stenting",
    "option_c": "DAPT",
    "option_d": "Exchange transfusion",
    "option_e": "",
    "correct_answer": "D",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Patients with sickle cell disease (SCD) are at increased risk for cerebrovascular complications, including stroke. The underlying hemoglobinopathy leads to chronic hemolysis and vaso-occlusion, predisposing patients to both infarcts and vascular stenoses. In SCD, repeated sickling episodes cause endothelial damage and intimal hyperplasia, resulting in vascular stenosis or occlusion. Severe intracranial stenosis, particularly in the middle cerebral artery (MCA), can precipitate cerebral infarction due to impaired blood flow. Exchange transfusion reduces the proportion of abnormal hemoglobin (HbS) and improves oxygen delivery. Clinically, SCD patients presenting with stroke symptoms and evidence of intracranial stenosis require prompt treatment to prevent further ischemic injury. Exchange transfusion is the frontline therapy aimed at reducing HbS levels while minimizing blood viscosity and the risk of further vaso-occlusive events. Differential diagnoses in this context include thrombotic stroke due to other causes (like cardioembolism or atherosclerosis) and vasculitic processes. Neuroimaging (MRI/MRA) combined with a thorough hematologic evaluation helps differentiate SCD-related stroke from other etiologies. The current standard of care for an SCD patient with stroke involves urgent exchange transfusion, which rapidly decreases the HbS concentration and reduces ongoing ischemia. This is supported by guidelines and studies (such as the STOP trials) and is considered first-line therapy. In pregnancy and lactation, transfusion therapy remains the mainstay, with careful monitoring and matched blood products to avoid alloimmunization and other complications. Option D (Exchange transfusion) is correct because it directly addresses the underlying sickling and vaso-occlusion process by reducing HbS levels. Option A (ASA) is not sufficient for the acute management of SCD stroke; Option B (Stenting) and Option C (DAPT) have not been shown to be effective or safe primary treatments in this unique patient population. 1. SCD increases the risk of stroke due to repeated vascular injury. 2. Exchange transfusion is critical in rapidly reducing pathological HbS levels during an acute stroke. 3. Chronic transfusion therapy may be required for secondary stroke prevention. Recent updates and clinical trials (including the STOP trial series) reinforce exchange transfusion as the primary intervention in SCD-related stroke. Guidelines from hematology and neurology societies emphasize rapid reduction of HbS via exchange transfusion to mitigate further ischemic injury.",
    "exam_year": "2020",
    "exam_type": "Part II"
  },
  {
    "question": "Scenario about CVT what will confirm diagnosis:",
    "option_a": "CTV",
    "option_b": "If mri choose it",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "Cerebral venous thrombosis (CVT) is a condition where thrombus formation in the cerebral venous sinuses leads to impaired cerebral venous drainage. Its clinical presentation can be subtle and variable, making imaging critical for confirmation. In CVT, thrombus formation within the cerebral venous system results in venous congestion, increased intracranial pressure, and potentially venous infarctions or hemorrhages. The disruption of normal venous drainage may be due to hypercoagulable states, infections, or other risk factors. Patients with CVT often present with headache, focal neurological deficits, seizures, or signs of increased intracranial pressure such as papilledema. Accurate diagnosis is essential to initiate appropriate anticoagulation therapy and prevent complications. The differential diagnosis for CVT includes intracerebral hemorrhage, arterial ischemic stroke, and benign intracranial hypertension. MRI with MR venography (MRV) is typically the modality of choice because of its high sensitivity and specificity, while CT venography (CTV) is a reasonable alternative when MRI is unavailable. Once diagnosed, the mainstay of treatment for CVT is anticoagulation, typically initiated with heparin (unfractionated or low-molecular-weight) even in the presence of hemorrhage. For pregnant or lactating patients, low-molecular-weight heparin is preferred due to its safety profile. Long-term management may include oral anticoagulants. Confirmatory imaging with MRI/MRV guides these decisions. Option B (If MRI choose it) is interpreted as advocating for an MRI-based approach (typically MRI with MR venography), which is the preferred modality for confirming CVT given its superior soft-tissue contrast and ability to directly visualize the thrombus. Option A (CTV) is also acceptable but is generally considered second-line when MRI is accessible. 1. CVT can present with nonspecific symptoms, making advanced imaging essential. 2. MRI with MR venography is the gold standard for diagnosing CVT. 3. Early anticoagulation improves outcomes in CVT even when a hemorrhagic component is present. Latest guidelines by the AHA/ASA and various neuroimaging consensus statements highlight that MRI with MRV is the confirmatory imaging of choice for CVT due to its high sensitivity and absence of radiation, although CT venography remains a good alternative in settings where MRI is not feasible.",
    "exam_year": "2020",
    "exam_type": "Part II"
  }
]